Valuation Corbus Pharmaceuticals Holdings, Inc.
Stocks
CRBP
US21833P3010
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-11-18 EST
|
5-day change | 1st Jan Change | ||
| 2.745 USD | -8.80% |
|
-31.38% | -66.28% |
Company Valuation: Corbus Pharmaceuticals Holdings, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 77.1 | 13.84 | 26.72 | 143.7 | 150.8 | 56.57 | - | - |
| Change | - | -82.05% | 93.01% | 437.89% | 4.94% | -62.5% | - | - |
| Enterprise Value (EV) | 77.1 | 13.84 | 26.72 | 143.7 | 150.8 | 56.57 | 56.57 | 56.57 |
| Change | - | -82.05% | 93.01% | 437.89% | 4.94% | -62.5% | 0% | 0% |
| P/E | -1.66x | -0.33x | -0.59x | -3.21x | -1.38x | -0.44x | -0.55x | -0.52x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.04x | -0.37x | 0x | -0x | -0.08x | 0x | -0.08x |
| Capitalization / Revenue | 87.4x | - | - | - | - | - | 28.1x | 25.3x |
| EV / Revenue | 0x | - | - | - | - | - | 28.1x | 25.3x |
| EV / EBITDA | - | - | - | -0x | - | -0.45x | -0.5x | -0.33x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -0.45x | -0.42x | -0.32x |
| EV / FCF | -0x | -0x | - | -0x | -0x | -0.72x | -0.43x | -0.38x |
| FCF Yield | -62.6% | -271% | - | -29.1% | -42.8% | -140% | -231% | -264% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -11.1 | -10.15 | -10.31 | -3.68 | -5.9 | -6.219 | -4.954 | -5.27 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.8817 | - | - | - | - | - | 2.011 | 2.233 |
| EBITDA 1 | - | - | - | -48.13 | - | -126.1 | -112.4 | -171.2 |
| EBIT 1 | -55.99 | -39.84 | -45.08 | -48.72 | -85.31 | -125.3 | -135.6 | -178.9 |
| Net income 1 | -45.64 | -42.35 | -44.6 | -40.21 | -78.54 | -126.3 | -137.1 | -177.5 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 18.471 | 3.315 | 6.040 | 11.800 | 8.140 | 2.745 | 2.745 | 2.745 |
| Nbr of stocks (in thousands) | 4,174 | 4,176 | 4,424 | 12,179 | 18,529 | 20,607 | - | - |
| Announcement Date | 3/8/22 | 3/7/23 | 3/12/24 | 3/11/25 | 3/9/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.48x | - | - | - | 62.03M | ||
| 17.32x | 6.64x | 12.72x | 1.72% | 66.37B | ||
| 31.83x | 8.5x | 28.08x | 0.07% | 58.86B | ||
| 38.41x | 6.84x | 20.46x | 0.85% | 55.22B | ||
| 44.35x | 6.2x | 29.52x | -.--% | 47.21B | ||
| 33.62x | 3.22x | 13.9x | -.--% | 42.45B | ||
| 35.98x | 8.9x | 23.21x | 0.36% | 36.44B | ||
| -19.28x | 55.7x | -21.11x | -.--% | 35.19B | ||
| 41.59x | 8.02x | 26.91x | -.--% | 32.66B | ||
| -74.36x | 14.09x | -75.73x | -.--% | 26.73B | ||
| Average | 14.90x | 13.12x | 6.44x | 0.33% | 40B | |
| Weighted average by Cap. | 21.61x | 11.64x | 11.39x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CRBP Stock
- Valuation Corbus Pharmaceuticals Holdings, Inc.
Select your edition
All financial news and data tailored to specific country editions
















